Iron deficiency anemia in women: A practical guide to detection, diagnosis, and treatment

Obstetrical and Gynecological Survey

Volumn 70, Issue 5, 2015, Pages 342-353

  Friedman, Arnold J ^a,b   Shander, Aryeh ^b,c   Martin, Stephanie R ^d,e   Calabrese, Rebecca K ^f   Ashton, Maria E ^g   Lew, Indu ^h   Seid, Melvin H ⁱ   Goodnough, Lawrence Tim ^j  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^d ST FRANCIS MEDICAL CENTER   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY AT BUFFALO   (United States)

^g Ashton Medica   (United States)

^h Barnabas Health ^*  (United States)

ⁱ Lyndhurst Gynecologic Associates PA   (United States)

^j STANFORD UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL IRON; CYANOCOBALAMIN; FERRITIN; FERROUS FUMARATE; FERROUS GLUCONATE; FERROUS SULFATE; FOLIC ACID; HEMOGLOBIN; IRON; IRON DEXTRAN; IRON GLYCINATE; IRON POLYSACCHARIDE; TRANSFERRIN;

ADULT; AGED; ANAPHYLAXIS; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; EVIDENCE BASED PRACTICE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; IRON THERAPY; KIDNEY FUNCTION TEST; MEAN CORPUSCULAR VOLUME; PRACTICE GUIDELINE; PREGNANT WOMAN; TREATMENT DURATION; ANEMIA, IRON-DEFICIENCY;

ANEMIA, IRON-DEFICIENCY; FEMALE; HUMANS; IRON;

EID: 84930068828     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0000000000000172     Document Type: Article

References (91)

1. McLean E, Cogswell M, Egli I, et al. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2009; 12; 444-454
2. Looker AC, Dallman PR, Carroll MD, et al. Prevalence of iron deficiency in the United States. JAMA. 1997; 277; 973-976
3. Cao C, O'Brien K Pregnancy and iron homeostasis; an update. Nutr Rev. 2013; 71; 35-51
4. Public Health Service Healthy People 2000, National Health Promotion and Disease Prevention Objectives Washington, DC; US Department of Health and Human Services, Public Health Service; 1991. DHHS Publication no (PHS) 91-50212
5. US Department of Health and Human Services. Office of Disease Prevention and Health Promotion. Healthy People 2020. Washington, DC. Available at; http; //www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=29. Accessed April 8, 2014
6. Ando K, Morita S, Higashi T, et al. Health-related quality of life among Japanese women with iron-deficiency anemia. Qual Life Res. 2006; 15; 1559-1563
7. Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD); a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis. 2005; 45; 658-666
8. Jones M, Schenkel B, Just J, et al. Epoetin alfa improves quality of life in patients with cancer; results of meta-Analysis. Cancer. 2004; 101; 1720-1732
9. Hahn EA, Cella D, Chassany O, et al. Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clin Proc. 2007; 82; 1244-1254
10. Pollack S, George JN, Reba R, et al. The absorption of nonferrous metals in iron deficiency. J Clin Invest. 1965; 44; 1470-1473
11. Levy A, Fraser D, Katz M, et al. Maternal anemia during pregnancy is an independent risk factor for low birthweight and preterm delivery. Eur J Obstet Gynecol Rep Biol. 2005; 122; 182-186
12. Milman N. Postpartum anemia I; definition, prevalence, causes, and consequences. Ann Hematol. 2011; 90; 1247-1253
13. Perez EM, Hendricks MK, Beard JL, et al. Mother-infant interactions and infant development are altered by maternal iron deficiency anemia. J Nutr. 2005; 135; 850-855
14. Beard JL, HendricksMK, PerezEM, et al.Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr. 2005; 135; 267-272
15. Brabin BJ, Hakimi M, Pelletier D. An analysis of anemia and pregnancy-relatedmaternal mortality. J Nutr. 2001; 131; 604S-614S
16. PetranovicD, Batinac T, Petranovic D, et al. Iron deficiency anaemia influences cognitive functions. Med Hypotheses. 2008; 70; 70-72
17. Beard JL, Borel MJ, Derr J. Impaired thermoregulation and thyroid function in iron-deficiency anemia. Am J Clin Nutr. 1990; 52; 813-819
18. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr. 2001; 131; S568-S580
19. Metivier F, Marchais SJ, Guerin A, et al. Pathophysiology of anaemia; focus on the heart and blood vessels. Nephrol Dial Transplant. 2000; 15(suppl 3); 14-18
20. Herzog C. Presented at the 6th Annual Scientific Meeting of the Heart Failure Society of America; September 22-25, 2002, Boca Raton, FL. Abstract 226
21. Lozoff B, Jimenez E, Smith JB. Double burden of iron deficiency in infancy and low socioeconomic status; a longitudinal analysis of cognitive test scores to age 19 years. Arch Pediatr Adolesc Med. 2006; 160; 1108-1113
22. Bruner AB, Joffe A, Duggan AK, et al. Randomized study of cognitive effects of iron supplementation in nonanemic iron-deficient adolescent girls. Lancet. 1996; 348; 992-996
23. Six KM, Goyer RA. The influence of iron deficiency on tissue content and toxicity of ingested lead in rats. J Lab Clin Med. 1972; 79; 128-136
24. Barton JC, Conrad ME, Nuby S, et al. Effects of iron in the absorption and retention of lead. J LabClinMed. 1978; 92; 536-547
25. Watson WS, Morrison J, Bethel MI, et al. Food iron and lead absorption in humans. Am J Clin Nutr. 1986; 44; 248-256
26. Zlotkin S. Clinical nutrition; 8. The role of nutrition in the prevention of iron deficiency anemia in infants, children and adolescents. CMAJ. 2003; 168; 59-63
27. Alton I. Iron deficiency anemia. In; Stang M, Story M, eds. Guidelines for Adolescent Nutrition Services. Minneapolis, MN; Center for Leadership, Education and Training inMaternal and Child Nutrition, Division of Epidemiology and Community Health, School of Public Health, University of Minnesota; 2005; 101-108
28. Friedman A, Chen Z, Ford P, et al. Iron deficiency anemia in women across the life span. J Womens Health. 2012; 21; 1282-1289
29. Tamura T, Goldenberg RL, Hou J, et al. Cord serum ferritin concentrations and mental and psychomotor development of children at 5 years of age. J Pediatr. 2002; 140; 165-170
30. Vercellini P, Vendola N, Ragni G, et al. Abnormal uterine bleeding associated with iron-deficiency anemia. J Reprod Med. 1993; 38; 502-504
31. ShankarM, Chi C, Kadir RA. Reviewof quality of life; menorrhagia in women with or without inherited bleeding disorders. Haemophilia. 2008; 14; 15-20
32. Côté I, Jacobs P, Cumming DC. Work loss associated with increased menstrual loss in the United States. Obstet Gynecol. 2002; 100; 683-687
33. Côté I, Jacobs P, Cumming DC. Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol. 2003; 188; 343-348
34. Cs Philipp Faiz A, Dowling n, et al. Age and prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol. 2005; 105; 61-66
35. Pandya N, Bookhart B, Mody SH, et al. Study of anemia in longterm care (SALT); prevalence of anemia and its relationship with the risk of falls in nursing home residents. Curr Med Res Opin. 2008; 24; 2139-2149
36. Hong C, Falvey C, Harris T. Anemia and risk for dementia in older adults; findings from the Health ABC study. Neurology. 2013; 81; 528-533
37. Herzog CA, Muster HA, Li S, et al. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail. 2004; 10; 467-472
38. Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Morb Mortal Wkly Rep. 1998; 47; 1-36
39. Evidence Syntheses, No. 40. Oregon Evidence-Based Practice Center. Rockville, MD; Agency for Healthcare Research and Quality; 2006
40. Simon GR, Baker C, Barden GA, et al.; Committee on Practice and Ambulatory Medicine. Bright Futures Periodicity Schedule Workgroup. 2014 Recommendations for pediatric preventive health care. Pediatrics. 2014; 133; 568-570
41. American Academy of Family Physicians. Age Charts for Periodic Health Examination. Kansas City, MO; American Academy of Family Physicians; 1994. Reprint no. 510
42. ACOG Practice Bulletin No 95. Anemia in pregnancy. Obstet Gynecol. 2008; 112; 201
43. Bergmann RL, Richter R, Bergmann KF, et al. Prevalence and risk of early postpartum anemia. Eur J Obstet Gynecol Reprod Biol. 2010; 150; 126-131
44. Guyatt GH, Oxman AD, Ali M. Laboratory diagnosis of iron deficiency anemia. J Gen InternMed. 1992; 7; 145-153
45. British Committee for Standards in Haematology. UK guidelines on the management of iron deficiency in pregnancy. Available at; http; //www.bcshguidelines.com/documents/UK-Guidelines-iron-deficiency y-in-pregnancy.pdf. Accessed September 3, 2013
46. Zhu A, KaneshiroM, Kaunitz JD. Evaluation and treatment of iron deficiency anemia; a gastroenterological perspective.DigDis Sci. 2010; 55; 548-559
47. Goodnough LT, Mathias A, Earnshaw P, et al. Detection, evaluation, and management of perioperative anemia in the elective orthopedic surgery patient. NATA Guidelines. Br J Anaesth. 2011; 106; 13-22
48. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005; 352; 1011-1023
49. Shander A, CappelliniMD, Goodnough LT. Iron overload and toxicity; the hidden risk of multiple blood transfusions. Vox Sang. 2009; 97; 185-197
50. Morgan EH, Oates PS. Mechanisms and regulation of intestinal iron absorption. Blood Cells Mol Dis. 2002; 29; 384-399
51. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011; 117; 4425-4433
52. Johnson-Wimbly T, Graham D. Diagnosis and management of iron deficiency anemia in the 21st century. Ther AdvGastroenterol. 2011; 4; 177-184
53. Santiago P. Ferrous versus ferric iron formulations for the treatment of iron deficiency; a clinical overview. Sci World J. 2012; 2012; 846824
54. National Institutes of Health (NIH) Dietary supplement fact sheet; iron. Bethesda, MD. Available at; http; //ods.od.nih.gov/factsheets/Iron-HealthProfessional/. Accessed September 5, 2013
55. Arcangelo V, Peterson A. Chapter 55. Anemias (Kelly Barranger). Pharmacotherapeutics for Advanced Practice A Practical Approach. 2nd ed. Philadelphia, PA; LippincottWilliams and Wilkins; 2006; 800
56. Charytan C, QunibiW, Bailie GR. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis. Nephron Clin Pract. 2005; 100; c55-c62
57. Al-Momen AK, Al-Meshari A, Al-NuaimL, et al. Intravenous iron sucrose complex in the treatment of iron deficiency and anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996; 69; 121-124
58. Macdougall IC. Strategies for iron supplementation; oral versus intravenous. Kidney Int Suppl. 1999; 69; S61-S66
59. van Wyck DB, Roppolo M, Martinez CO, et al. for the United States Iron Sucrose (Venofer)Clinical TrialsGroup. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int. 2005; 68; 2846-2856
60. Agarwal R, Rizkala AR, Bastani B, et al. A randomized controlled trial of oral versus intravenous iron in chronic kidney disease. Am J Nephrol. 2006; 26; 445-454
61. Little DR. Ambulatory management of common forms of anemia. Am Fam Physician. 1999; 59; 1598-1604
62. Qunibi WY, Martinez C, Smith M, et al. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis dependent chronic kidney disease patients. Nephrol Dial Transplant. 2011; 26; 1599-1607
63. Li H, Wang SX. Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. Perit Dial Int. 2008; 28; 149-154
64. Spinowitz BS, Kausz AT, Baptista J, et al. Ferumoxytol for treating iron deficiency anemia in CKD. J Am Soc Nephrol. 2008; 19; 1599-1605
65. Besarab A, Amin N, Ahsan M, et al. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol. 2000; 11; 530-538
66. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13; 1545-1553
67. BreymannC. The use of iron sucrose complex for anemia in pregnancy and the postpartum period. Semin Hematol. 2006; 43 (suppl 6); S28-S31
68. van Wyck DB, Mangione A, Morrison J, et al. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding; a randomized, controlled trial. Transfusion. 2009; 49; 2719-2728
69. Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Hematol. 2009; 122; 78-86
70. Auerbach M, Coyne D, Ballard H. Intravenous iron; from anathema to standard of care. Am J Hematol. 2008; 83; 580-588
71. Aronoff GM, Bennett WM, Blumenthal S, et al. Iron sucrose in hemodialyisis patients; safety and efficacy of iron replacement and maintenance therapy. Kidney Int. 2004; 66; 1193-1198
72. Chertow GM, Mason PD, Vaage-Nilsen O, et al. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant. 2006; 21; 378-382
73. Michael B, Coyne DW, Fishbane S, et al. Sodiumferric gluconate complex in hemodialysis patients; adverse reactions compared to placebo and iron dextran. Kidney Int. 2002; 61; 1830-1839
74. Coyne DW, Adkinson NF, Nissenson AR, et al. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-Tolerant patients. Kidney Int. 2003; 63; 217-224
75. Bailie GR. Comparison of rates of reported adverse events associated with I.V. iron products in the United States. Am J Health Syst Pharm. 2012; 69; 310-320
76. Charytan C, Schwenk MH, Al-Saloum MM, et al. Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products. Nephron Clin Pract. 2004; 96; c63-c66
77. Peebles G, Stanley S. Evaluation of service reconfiguration for managing intravenous iron supplementation in non-hemodialysis patients with chronic renal failure. J Outcomes Res. 2004; 8; 15-25
78. InFeD [package insert].Morristown, NJ; Watson Pharma, Inc; 2009
79. Dexferrum [package insert]. Shirley, NY; AmericanRegent, Inc; 2008
80. Venofer [package insert]. Shirley, NY; American Regent, Inc; 2011
81. Ferrlecit [package insert]. Bridgewater, NJ; Sanofi Aventis, Inc; 2011
82. Feraheme [package insert]. Lexington, MA; AMAG Pharmaceuticals, Inc; 2009
83. Injectafer [package insert]. Shirley, NY; American Regent, Inc; 2013
84. QunibiW, Dinh Q, Benjamin J Safety and tolerability profile of ferric carboxymaltose (FCM) a new high dose intravenous iron, across ten multi-center trials. J AmSocNephrol. 2007; 18; SU-PO1029
85. Reveiz L, Gyte GM, Cuervo LG, et al. Treatments for irondeficiency anemia in pregnancy. Cochrane Database Syst Rev. 2011; CD003094
86. Kim YH, Chung HH, Kang SB, et al. Safety and usefulness of intravenous iron sucrose in themanagement of preoperative anemia in patients with menorrhagia; a phase IV, open label, prospective, randomized study. Acta Haematol. 2009; 121; 37-41
87. Breymann C, Visca E, Huch R, et al. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. Am J Obstet Gynecol. 2001; 184; 662-667
88. Goodnough LT, Schrier SL. Evaluation and management of anemia in the elderly. Am J Hematol. 2014; 89; 88-96
89. Breymann C, Richter C, Huttner C, et al. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patientswith postpartumanaemia and blunted erythropoiesis. Eur J Clin Invest. 2000; 30; 154-161
90. Ganzoni AM. Intravenous iron-dextran; therapeutic and experimental possibilities. Schweiz Med Wochenschr. 1970; 100; 301-303
91. Aetna Clinical Policy Bulletin; intravenous iron therapy Available at; http; //www.aetna.com/cpb/medical/data/500-599/0575. html. Accessed September 21, 2013